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Childhood Lead Poisoning 
Raj P. Warrier, MBBS, M D , DCH,* Jan Waisanen, RN,t Sam R. Kottamasu, MD,* 
Sayeeda Sultana, MD,§ K. Ratnakar Kini, MD,II Wil l iam L. Kestenberg, MD,1 
John Strauthers, BS,* and Craig Foreback, PhD** 
Although lead encephalopathy is rare, lead intoxication 
continues to be a significant problem in Detroit. Neuropsy-
chological effects may occur even at low levels oflead. Since 
treatment of lead poisoning consists of a painful series of 
injections, it is imperative that more attention be given to 
the prevention of this disease. To confirm the magnitude of 
the problems, our experience with lead poisoning during a 
three-year period at Henry Ford Hospital's Pediatric Depart-
ment is reviewed. 
Since its discovery about 5,000 years ago, lead has become 
an increasingly essential part of daily life. Some current uses 
ofthis metal include gasoline, food cans, lead acid batteries, 
and electronic gadgets. Although lead has no physiological 
role in the body, subclinical effects of lead poisoning, 
particularly central nervous system effects, have been 
detected in children having minimally elevated blood levels 
(1,2). Each year about 7% of the children tested are found 
to have undue lead absorption, with about 0.4% of them 
being in the highest risk category (3-5). Our experience with 
lead poisoning in children during a three-year period at 
Henry Ford Hospital is reviewed herein. 
Materials and Methods 
At Henry Ford Hospital, lead levels were measured by 
atomic absorption spectrophotometry, and erythrocyte pro-
toporphyrin (EP) concentration (normal: 20 fig/dL) was 
measured fluorometrically (6). Lead levels were measured 
by the Detroit Health Department Laboratories by anodic 
stripping voltammetry. Patients with beta-thalassemia trait 
or sickle-cell hemoglobin were identified by hemoglobin 
electrophoresis. Serum ferritin level was measured by 
radioimmunoassay (7). The criteria for diagnosing anemia 
included 1) hemoglobin value below 11.0 g/dL for children 
between 0.5 to 6 years and 2) hemoglobin value below 11.5 
g/dL for children between 6 and 12 years (normal: 12.0 
g/dL; range: 10.5 to 14.0). Iron deficiency was defined as 
ferritin level below 10 /xg/L (normal: 10 to 300 /J-g/L) and/or 
transferrin saturation below 16% (normal: 20% to 55%) 
(8,9). Radiographs of the abdomen and long bones were also 
performed on these children. 
Results 
The Pediatrics Department at Henry Ford Hospital serves 
as a tertiary referral center for the Detroit Lead Control 
Program, which screened 53,896 children from Jan 1, 1980, 
to Dec 31, 1982. Elevated lead (Pb) or EP levels were found 
in 2,045 (3.78%) of the children. Ninety-eight cases (0,18% 
of the total, or 4 .7% of the positive cases) were Class IV 
by the risk categorization (Table). During the three-year 
period at the hospital, 55 children, including patients in the 
Detroit Lead Control Program and those from other referral 
sources, underwent chelation therapy. 
Of the 55 children treated for lead poisoning during the 
three-year period, 46 (84%) patients were categorized as 
Class IV and nine (16%) as Class III patients, based on the 
Centers for Disease Control (CDC) critena for risk classifica-
tion of children with lead poisoning. Multiple chelations 
were required in four cases, including five chelations in one 
instance. 
Submitted for publication; December 10, 1984 
Accepled for publication: August 28, 1985 
'Louisiana State University tvledlcal Center, New Orleans, Louisiana. 
Formerly Department of Pediatrics, hienry Ford Hospital 
'Outpatient Division, Henry Ford Hospital 
'Department of Radiology, Division of Pediatric Radiology, Henry Ford Hospital 
^Detroit Health Deparlment. Formerly Plymouth Center, Henry Ford Hospital 
'department of Pediatrics, Henry Ford Hospital 
^Mt Carmel Hospital, Detroit, tvlichigan. Formerly University of fvlichigan fvledical 
School 
*Det ro i l Health Department, Lead Poison Control Unit 
• 'Department of Pathology, Division of Chemistry, Henry Ford Hospital 
Address reprint requests to Dr Warrier, Deparlment of Pediatrics, Louisiana State 
University Medical Center, 1542 Tulane Ave, New Orleans, LA 70112. 
205 
Warrier, Waisanen, Kottamasu, et al 




Risk Classification of Asymptomat ic Chi ldren, 
Adapted f rom Centers for Disease Control (3) 
Erythrocyte Protoporphyrin (fig/dL Whole Blood) 
<49 50-109 110-249 >250 
<29 1 la 1a EPP* 
30-49 l b II 111 111 
50-69 xx' III 111 IV 
>70 XX XX IV IV 
•Erythropoietic protoporphyria. Iron deficiency may cause EP elevations to 300 ftg/dL, 
although rarely. 
txx = Combination of results not generally observed in practice 
The children's ages ranged from 16 months to 108 months 
(m: 33.6 months). Existing neurological problems such as 
mental retardation and seizure disorder were noted in four 
(7.2%) children, and clinical symptoms attributable to lead 
poisoning were noted in seven (13%). Pica was present in 
46 (84%) of the patients. Radiopaque paint chips in the 
intestinal tract were noted on abdominal radiographs in 21 
(39%) children. Radiographs of the long bones showed 
thick, transverse, radiodense, metaphyseal bands in 22 
(40%) of these cases. 
Lead levels ranged from 45 p-gldl to 111 /xg/dL (m: 68 
p.gldl), EP levels from 110 fj,g/dL to 801 jxg/dL (m: 290 
jLtg/dL), and hemoglobin from 6.8 g/dL to 13,5 g/dL (m: 
10.6 g/dL), Mean corpuscular volume varied from 54 fL to 
85 fL (m: 73 fL), The serum ferritin range was from 8 fxg/dL 
to 40 /j,g/dL (m: 20 jug/dL), Forty-four (80%) of these 
children were tested for iron deficiency; 39% were found 
to be iron deficient by at least one of the criteria for iron 
deficiency, and 50% were anemic. Sickle-cell trait was 
detected in two instances, sickle beta-thalassemia in one 
case, beta-thalassemia minor in two cases, and hemoglobin 
AC trait in one instance. 
Discussion 
Current research in lead poisoning is centered on the 
prevention and early detection of subtle neuropsychological 
defects, the effects of lead on various enzyme systems, and 
the interaction of nutrition with lead toxicity. Lead en-
cephalopathy may be rare, but the risk of lead poisoning is 
not solely restricted to residents of old, dilapidated housing 
(10) or to urban migrant families. 
All the children in our study were from the Detroit and 
Highland Park inner city areas. Sachs et al (11) reviewed 
their experience with 1155 children in an urban setting and 
noted pica in 74% of their patients. Radiodense, meta-
physeal lines in long bones were detected in 82%. In our 
patients pica was present in 84% and metaphyseal lines in 
4 0 % (Fig 1). 
Evidence of paint chips in the intestinal tract (Fig 2) was 
noted radiologically in 39% of the children in our study, as 
compared to 1 7% of those with lower levels of lead and 
100% of those with blood lead levels approaching 100 
jLig/dL in the Sachs et al series (11). 
Lead affects metabolism through its action on enzyme 
systems. The hematopoietic effect of lead is a sensitive 
indicator of the metal's metabolic effects at cellular and 
functional levels. Microcytic, hypochromic anemia with 
basophilic stippling of the red blood cells is often the clinical 
end-point of hematological changes. Basophilic stippling is 
not useful for determining exposure to lead because it is 
nonspecific; dose-response data are not yet available. 
Elevation of EP levels is an eady manifestation of hematopoi-
etic effects that ultimately may induce anemia. Anemia 
accompanying lead poisoning involves a multitude of factors 
(12); Yip et al (13) noted a 30% incidence of anemia in 
lead-intoxicated children. Of the children in our study, 50% 
were anemic, and 44% were iron deficient. Cohen et al (14) 
believed that if iron deficiency and thalassemia were 
excluded, microcytic, hypochromic anemia would be un-
common in lead poisoning. 
Multiple chelations were required in four of our patients, 
including five chelations for one patient. All the children 
tolerated the chelations with calcium EDTA and British 
antilewisite administered in accordance with the CDC 
protocol (3). These drugs were administered with procaine 
hydrochloride (Elkinson-Sinn, Cherry Hill, NJ) and hyaluron-
idase to try to decrease local pain and inflammation. The 
lack of abscess formation or severe restriction of physical 
activity may indicate potential benefit with use of these 
drugs; however, the long and painful series of injections is 
a major drawback of the treatment program. Chelations had 
to be repeated in 7% of the cases because lead levels did 
not decrease to low-risk categories. A recurrence rate of 3% 
was noted in the Sachs et al experience. 
Despite preventive measures and screening programs, lead 
poisoning continues to be a significant problem. Neuropsy-
206 
C h i l d h o o d Lead P o i s o n i n g 
Fig 1 
Dense, transverse, metaphyseal bands involving bones of knee. 
chological, hematological, and other complications con-
tinue to arise because of low-level chronic lead poisoning. 
Significant biochemical alterations with subtle neuropsy-
Fig 2 
Scattered radiopaque particulate material in intestinal tract consistent 
w i th pica. 
chological changes may result from chronic low-level lead 
poisoning (15,16), and significant behavioral and intellectual 
defects may occur, especially in young, growing children. 
Deficits in fine motor function, attention disorders, learning 
disabilities, or emotional disturbances that impair young 
children's progress at school and in society may all be 
manifestations of subclinical chronic lead poisoning (1 7), as 
a consequence of prenatal and neonatal lead exposure (18). 
It remains imperative for the pediatric team to continue to 
work closely with the community, government, and social 
workers in the prevention, early detection, and appropriate 
treatment of lead poisoning in children. 
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